Live
- TN Police targeting me in Rs 4 cr cash seizure case, says BJP leader Nainar Nagendran
- Former Zimbabwe cricketer Guy Whittall injured by leopard
- Fatal Fire Erupts In Hotel Near Patna Junction, Claims Six Lives
- Congress Challenges PM Modi's Allegations: Calls Out "Falsehoods" Amidst Electoral Rhetoric
- CPI(M) leader seeks Calcutta HC’s attention over Bengal CM's anti-judiciary comments
- Aparna Yadav Challenges Akhilesh Yadav's Candidacy In Kannauj: No Longer A Smooth Ride For Samajwadi Party
- A constable who helped an old woman in a very dangerous place
- WBSSC Claims Eligibility For 19,000 Dismissed Staff Amidst Teacher Recruitment Scandal
- Tollywood’s shifting landscape: The growing influence of OTT platforms
- YSR Congress Party MLA candidate KK Raju campaigns in 23rd Ward Priyadarshini Colony
Dr Reddy's launches heartburn capsules in US market
Drug firm Dr Reddy's Laboratories on Monday said it has launched over-the-counter Lansoprazole capsules used for treatment of frequent heartburn in the US market.
Hyderabad: Drug firm Dr Reddy's Laboratories on Monday said it has launched over-the-counter Lansoprazole capsules used for treatment of frequent heartburn in the US market.
The company has launched Lansoprazole delayed-release capsules USP in the strength of 15 mg in the US market, as approved by the United States Food and Drug Administration (USFDA), Dr Reddy's said in a BSE filing.
"We are pleased to continue to expand our antacids and PPI portfolio for our customers," Dr Reddy's Laboratories Senior Vice President and Head of US OTC and Specialty Rx Divisions Milan Kalawadia said.
The company's product is over-the-counter store-brand equivalent to Takeda Pharmaceuticals North America Inc's Prevacid 24HR capsules, the company said.
